Growth Capital Focus 1315 Capital specializes in expansion and growth capital for commercial healthcare entities, medical technology, medtech and pharma outsourcing, and health and wellness sectors, signaling potential sales opportunities with provider and device companies seeking scale and exit readiness.

Mid-Market Target The firm targets investments in the $10-$40 million range with aims to scale to around $100 million in revenue, indicating a focus on mid-sized healthcare companies that may need strategic services, equipment, or technology partnerships to reach scale.

Operating Partner Model With an operating partner approach including a CEO and Right Hand COO, 1315 Capital collaborates closely on diligence and growth decisions, suggesting opportunities for high-touch advisory services, interim leadership, and optimization solutions.

Recent Portfolio Momentum Active investments and acquisitions including Spineology, Codis, Uspharma, Coating Place, and a notable SciSafe acquisition signal ongoing deal flow and potential co-investment or syndicated financing opportunities across medical devices, pharma outsourcing, and contract development sectors.

Financial and Market Signals Annual revenue reported in the range of 25–50 million with a full-service healthcare and medtech focus, indicating a market segment with appetite for growth capital, exit planning services, and value-added partnerships to accelerate scale for potential exits.